Ahmedabad, May 14, 2017: Ahmedabad based multinational pharmaceutical company Torrent Pharma, today announced that it has completed the acquisition of Regestrone and Pregachieve brands for India from global Pharma player Novartis AG of Switzerland.
Executive Director of the company Jayesh Desai said that these brands were widely prescribed by Gynaecologists for the management of Abnormal Uterine bleeding, Peri & Post- menopausal symptoms and Infertility.
”Women Healthcare is an important therapy area for Torrent Pharma, which it intends to focus in the future. With acquisition of key brands of Elder like Shelcal and Deviry, impetus on this therapy area has also increased. Regestrone and Pregachieve will further fortify the Hormone Segment. The use of Hormones amongst the Gynaecologists is on an increase because of lifestyle changes. This acquisition would reaffirm Torrent’s commitment towards the key important therapy of women healthcare,’ he said.
Notably Torrent Pharma, with annual revenues of more than Rs. 6600 crores is the flagship Company of the Rs. 18,300 crores Torrent Group. It continues to be at the forefront of the Indian pharmaceutical industry with many of its products ranking amongst the top 500 brands (AIOCD Dataset) in India. Its widespread international presence also includes several markets where Torrent is amongst the leading pharmaceutical companies in the respective countries. –United News of India
